会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • System and method for monitoring and controlling the glycemic state of a patient
    • 用于监测和控制患者血糖状态的系统和方法
    • US06572542B1
    • 2003-06-03
    • US09518796
    • 2000-03-03
    • Richard HoubenVincent Larik
    • Richard HoubenVincent Larik
    • A61B500
    • A61B5/0472A61B5/14532A61B5/7264A61M5/14244A61M2230/04A61M2230/201G06F19/00G06F19/3468G16H50/20Y10S128/92Y10S128/925
    • Information derived from ECG signals and EEG signals may be employed in combination to reliably predict the onset, or to indicate the presence of, hypoglycemia in a human patient. In one embodiment, ECG and EEG signals are processed and the information derived from them is combined to determine whether a patient suffering from diabetes is undergoing a hypoglycemic event, or whether such an event is imminent. Input data from the patient or a health care provider may also be used to increase the accuracy and reliability of the system. Detection of a hypoglycemic event by the system can result in the output of an alarm signal and/or the delivery or administration of a beneficial agent such as insulin, glucagon or diazoxide to the patient. The system may be implantable, external, or a combination of external and implantable components. The control strategy of the present system is preferably microprocessor based and/or implemented using dedicated electronics. In another embodiment, the glycemic state of the patient is continuously or relatively continuously monitored and controlled by the system. The system may contain any of a number of different types of feedback control systems for monitoring the glycemic state of a patient and controlling same, such as fuzzy logic systems, adaptive systems, reinforcement learning systems, and the like.
    • 从ECG信号和EEG信号得到的信息可以组合使用以可靠地预测人类患者的发作或低血糖的存在。 在一个实施例中,处理ECG和EEG信号,并且从它们得到的信息被组合以确定患有糖尿病的患者是否正在经历低血糖事件,或者这种事件是否即将来临。 还可以使用来自患者或医疗保健提供者的输入数据来提高系统的准确性和可靠性。 通过系统检测低血糖事件可以导致警报信号的输出和/或向患者输送或施用有益剂例如胰岛素,胰高血糖素或二氮嗪。 该系统可以是可植入的,外部的或外部的和可植入的组件的组合。 本系统的控制策略优选是基于微处理器的和/或使用专用电子设备实现的。 在另一个实施方案中,患者的血糖状态由系统连续或相对连续地监测和控制。 该系统可以包含许多不同类型的反馈控制系统中的任何一种,用于监视患者的血糖状态并控制其,例如模糊逻辑系统,自适应系统,强化学习系统等。
    • 4. 发明授权
    • Cell-based biosensors suitable for implantable medical device applications
    • 适用于可植入医疗器械应用的基于细胞的生物传感器
    • US06605039B2
    • 2003-08-12
    • US09909999
    • 2001-07-23
    • Richard HoubenVincent Larik
    • Richard HoubenVincent Larik
    • A61B500
    • A61B5/01A61B5/14532
    • A sensing methodology is used based on measuring a physical response from a living structure as a result of a chemical compound stimulating this structure on the cellular level. Measurement of the heat response (calorimetry) from a group of pancreatic islets of Langerhans stimulated by glucose is proposed as a glucose biosensor. A novel biosensor concept is proposed acquiring physical response from living cells or cell clusters. In this particular case, membrane impedance of pancreatic B-cells, as a result of glucose stimulated cellular metabolism is used as physical readout. This method of physical assessment is made possible by growing genetically engineered pancreatic beta cells onto a substrate equipped with a set of interdigitated electrodes (IDEs).
    • 基于在细胞水平上刺激该结构的化学化合物的结果,基于测量来自活体结构的物理反应的感测方法被使用。 作为葡萄糖生物传感器,提出了一组由葡萄糖刺激的朗格汉斯胰岛的热响应(量热法)的测量。 提出了一种新的生物传感器概念,从生物细胞或细胞簇获得物理反应。 在这种特殊情况下,作为葡萄糖刺激的细胞代谢的结果,胰腺B细胞的膜阻抗用作物理读数。 通过将基因工程的胰β细胞生长到配备有一组交叉电极(IDE)的基底上,这种物理评估方法成为可能。
    • 5. 发明申请
    • Algorithms for detecting cardiac arrhythmia and methods and apparatuses utilizing the algorithms
    • 用于检测心律失常的算法和利用算法的方法和装置
    • US20060167364A1
    • 2006-07-27
    • US11043584
    • 2005-01-26
    • Richard Houben
    • Richard Houben
    • A61B5/04
    • A61B5/0464A61B5/046A61B5/726G06K9/00557
    • A method for detecting a cardiac arrhythmia from an electrocardiogram includes the steps of identifying a plurality of R-waves in the electrocardiogram during a predetermined time interval; extracting heartbeat complexes corresponding to the identified R-waves; identifying a key region within each heartbeat complex that is morphologically altered in the event of the cardiac arrhythmia; calculating a statistical measurement of an ensemble of the key regions from each of the heartbeat complexes; and determining from the statistical measurement whether the cardiac arrhythmia occurred during the predetermined time interval. An apparatus is also provided that includes a processor that is coupled to receive an electrocardiogram, and is configured in response thereof to perform the method for detecting a cardiac arrhythmia.
    • 一种用于从心电图检测心律不齐的方法包括以下步骤:在预定的时间间隔内识别心电图中的多个R波; 提取与所识别的R波相对应的心跳复合体; 识别在心律失常的情况下在形态上改变的每个心跳复合物内的关键区域; 计算来自每个心跳复合体的关键区域的整体的统计测量; 以及从所述统计测量确定在所述预定时间间隔期间是否发生心律失常。 还提供了一种装置,其包括耦合以接收心电图的处理器,并且被配置为响应于此执行用于检测心律失常的方法。
    • 6. 发明授权
    • Telemetry system with phase-locking noise suppressing receiver
    • 具有锁相噪声抑制接收机的遥测系统
    • US06329929B1
    • 2001-12-11
    • US09217127
    • 1998-12-21
    • Koen J. WeijandRichard Houben
    • Koen J. WeijandRichard Houben
    • G08C1916
    • H04L25/062A61N1/08H04L27/10Y10S128/903
    • There is provided a telemetry system with a receiver which enables detection of pulsed high frequency data (hf) signals in a manner which suppresses noise which may be present within the high frequency bandwidth. The transmitter carrier, which may be subject to some instability, is encoded at a symbol rate which is generated at a lower frequency than the hf, but which is reliably stable. The receiver detects the phase of each received hf pulse, and generates a phase-locked signal which is synchronized to the transmitter symbol signal. The phase-locked signal in turn is used to demodulate the received pulsed signals. In a specific DSP embodiment, the phase-lock loop has a numerically controlled oscillator which has a center frequency which corresponds to the aliased phase difference between the hf carrier phase and the phase of each pulse, thereby obtaining a signal which carries information as to the exact symbol rate. This information is used either to calculate the timing of a narrow window which gates a pulse detector coincident with each next expected symbol time, or to trigger generation of a replica signal which is used in the detect circuit, thereby providing high resolution detection of the pulses and good noise rejection.
    • 提供了一种具有接收器的遥测系统,其能够以抑制可能存在于高频带宽内的噪声的方式检测脉冲高频数据(hf)信号。 可能受到一些不稳定性的发射机载波以以比hf低的频率产生的符号速率被编码,但是其可靠地稳定。 接收机检测每个接收到的hf脉冲的相位,并产生与发射机符号信号同步的锁相信号。 锁相信号依次用于解调所接收的脉冲信号。 在特定DSP实施例中,锁相环具有数控振荡器,其具有对应于hf载波相位和每个脉冲的相位之间的混叠相位差的中心频率,从而获得载有关于 精确符号率。 该信息用于计算与每个下一个预期符号时间一致的脉冲检测器的窄窗口的定时,或者触发在检测电路中使用的复制信号的产生,从而提供脉冲的高分辨率检测 和良好的噪音抑制。
    • 8. 发明授权
    • System and method for continuous monitoring of diabetes-related blood
constituents
    • 连续监测糖尿病相关血液成分的系统和方法
    • US5741211A
    • 1998-04-21
    • US548784
    • 1995-10-26
    • Alexis C. M. RenirieRichard HoubenFrank van Leeuwen
    • Alexis C. M. RenirieRichard HoubenFrank van Leeuwen
    • A61B5/00
    • A61B5/14532Y10S128/92
    • A system and method for sensing and providing an indication of one or more diabetes-related blood constituents of a patient, the system being based upon an ECG sensor which processes patient ECG signals, either surface, or intracardiac or epicardial, for determining a measure of a blood constituent such as insulin or glucose, or both insulin and glucose. The system has processing capability for correlating selected parameters of the ECG signal with patient blood insulin or blood glucose, to provide the insulin or glucose level. Additionally, the system is provided with input capability for enabling the patient to input data such as the time of meal intake, which is representative of glucose intake, which data is incorporated in making a determination of patient insulin need. The system can be in a first external wearable embodiment, or in a second implantable embodiment which utilizes a pacing-type lead for picking up intracardiac or epicardial signals. In either the wearable or implantable embodiment, the output response may be simply an indication of patient insulin and/or glucose need provided by an external display, and may also include automatic control of insulin injection to the patient.
    • 一种用于感测和提供患者的一种或多种与糖尿病相关的血液成分的指示的系统和方法,所述系统基于处理患者ECG信号(表面或心内或心外膜)的ECG传感器,用于确定 血液成分如胰岛素或葡萄糖,或胰岛素和葡萄糖两者。 该系统具有将ECG信号的选定参数与患者血液胰岛素或血糖相关联的处理能力,以提供胰岛素或葡萄糖水平。 此外,该系统具有输入能力,使得患者能够输入诸如饮食时间的数据,其代表葡萄糖摄取,该数据被纳入以确定患者胰岛素需要。 该系统可以在第一外部穿戴性实施例中,或者在利用起搏型引线拾取心内或心外膜信号的第二可植入实施例中。 在可穿戴或可植入的实施例中,输出响应可以简单地是由外部显示器提供的患者胰岛素和/或葡萄糖需求的指示,并且还可以包括对患者的胰岛素注射的自动控制。
    • 10. 发明授权
    • Deep trench semiconductor capacitors having reverse bias diodes for implantable medical devices
    • 具有用于可植入医疗器件的反向偏置二极管的深沟槽半导体电容器
    • US06484054B2
    • 2002-11-19
    • US09879282
    • 2001-06-12
    • Koen J. WeijandRichard Houben
    • Koen J. WeijandRichard Houben
    • A61N100
    • H01L29/66181A61N1/05H01L27/0805H01L29/945
    • Floating and non-floating on-chip capacitors are formed by vertical walls and/or large aspect ratio deep trenches disposed in semiconductor material. By optimizing the through spacing and substrate voltage, a very small parasitic to intended capacitance ratio may be obtained. Capacitors so formed may be used as on-chip charge storage and other types of on-chip capacitors, and eliminate or reduce the number of off-chip capacitors that would otherwise be required. The deep trench capacitors find particularly efficacious application in implantable medical devices where volume, cost and electrical energy consumption must be minimized, and preferably have capacitances which range between about 10 nF and about 1000 uF.
    • 浮置和非浮动片上电容器由设置在半导体材料中的垂直壁和/或大纵横比深沟槽形成。 通过优化通过间隔和衬底电压,可以获得非常小的寄生到预期电容比。 如此形成的电容器可以用作片上电荷存储和其他类型的片上电容器,并且消除或减少否则将要求的片外电容器的数量。 深沟槽电容器在体积,成本和电能消耗必须最小化的可植入医疗设备中特别有效,并且优选地具有介于约10nF至约1000uF之间的电容。